Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease
about
Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape.The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab networkHypophysitis: a single-center case series.Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-164Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissuesIpilimumab-induced autoimmune hypophysitis: a differential for sellar mass lesionsAnticytotoxic T-lymphocyte antigen-4 induced autoimmune hypophysitis: a case report and literature review.Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy.Update on hypophysitis and TTF-1 expressing sellar region masses.Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management.Ipilimumab-induced hypophysitis: review of the literature.Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathiesAdverse events of monoclonal antibodies used for cancer therapy.Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports.Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.Xanthomatous Hypophysitis Is Associated with Ruptured Rathke’s Cleft CystAn unsuspected complication with immune checkpoint blockade: a case report
P2860
Q27691824-167DA7A6-B8C5-432F-A0C4-030C1F3AB718Q28485085-7B389270-4388-439B-B8F4-80DE2D6572B7Q30881632-F287D828-E98F-4850-8EED-423E68B99680Q33658400-4CD38928-8F29-4550-B855-FBFCF1F8DCF3Q34443711-363F3A12-03E3-4C91-B248-7583731635CEQ34769437-DAC61F9F-41A5-4975-BBA2-8ED5FDD436D3Q35074088-C2FA6E4A-57ED-4F44-AFDA-AE6715A58BDCQ36173638-0DBE78FA-630D-4AB8-A72A-EFEB71194409Q37518341-DAD4E7E3-279D-46A1-9BAE-1068F4A864B7Q38108826-A723F5D9-3930-4A40-A9E7-E0EE5D2E22BFQ38166382-C17082F7-8D8C-4FD6-A9F8-BE69EA657C96Q38469194-51EC3F18-FB4E-419C-8E19-FD9CF4626F44Q38502692-DA9D8115-CE40-478C-BE99-3968BDACC440Q39010566-D8E95612-4227-47B9-BDF5-AD54F83C66D9Q40812370-FD1D346C-84DA-4F1A-A23E-493DF8CD9125Q45364903-B656CE7D-C768-46C2-9671-62EF33FD8F12Q46688417-37B4D06E-C037-4FF3-B715-C523B0BE5100Q53552401-62CB07B2-9680-4F24-89F1-B10068ED0444Q57793622-9F4B7468-49F9-480A-A31F-EE080805D133Q58765647-D83B14D8-D1CE-46F5-86BA-0AB35B4876C6
P2860
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hypophysitis induced by monocl ...... a new cause of a rare disease
@ast
Hypophysitis induced by monocl ...... a new cause of a rare disease
@en
type
label
Hypophysitis induced by monocl ...... a new cause of a rare disease
@ast
Hypophysitis induced by monocl ...... a new cause of a rare disease
@en
prefLabel
Hypophysitis induced by monocl ...... a new cause of a rare disease
@ast
Hypophysitis induced by monocl ...... a new cause of a rare disease
@en
P2093
P2860
P1433
P1476
Hypophysitis induced by monocl ...... a new cause of a rare disease
@en
P2093
Agnese Barnabei
Francesco Torino
Liana De Vecchis
Roberto Salvatori
Salvatore M Corsello
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0404
P577
2012-04-03T00:00:00Z